Although this protein can also be expressed in normal tissues, recent studies have shown that FSCN1 is up-regulated in many types of metastatic tumors, and its expression correlates with enhanced aggressiveness, poor prognosis, and reduced survival (4, 5, 7, 16). The gene discussed is FSCN1; the disease is metastatic neoplasm.